Growth Metrics

bioAffinity Technologies (BIAF) Receivables - Other (2022 - 2025)

Historic Receivables - Other for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to $27143.0.

  • bioAffinity Technologies' Receivables - Other fell 4482.35% to $27143.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $27143.0, marking a year-over-year decrease of 4482.35%. This contributed to the annual value of $27874.0 for FY2024, which is 568.13% down from last year.
  • Per bioAffinity Technologies' latest filing, its Receivables - Other stood at $27143.0 for Q3 2025, which was down 4482.35% from $19516.0 recorded in Q2 2025.
  • In the past 5 years, bioAffinity Technologies' Receivables - Other registered a high of $119363.0 during Q2 2024, and its lowest value of $4730.0 during Q3 2023.
  • Its 4-year average for Receivables - Other is $36138.5, with a median of $27508.5 in 2024.
  • Its Receivables - Other has fluctuated over the past 5 years, first surged by 94002.11% in 2024, then tumbled by 8364.99% in 2025.
  • Quarter analysis of 4 years shows bioAffinity Technologies' Receivables - Other stood at $10489.0 in 2022, then soared by 181.75% to $29553.0 in 2023, then decreased by 5.68% to $27874.0 in 2024, then dropped by 2.62% to $27143.0 in 2025.
  • Its Receivables - Other was $27143.0 in Q3 2025, compared to $19516.0 in Q2 2025 and $17381.0 in Q1 2025.